Daxor Submits Next-Gen Blood Volume Analyzer for FDA Clearance

Daxor submitted its next-generation blood volume analyzer—Daxor BVA—to the U.S. FDA via the 510(k)/CLIA-waiver dual submission pathway.

Clinical Lab Products